Alkem Laboratories (ALKEM) Share Price Falls 2.61% Today
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
Alkem Laboratories Share Price fell to Rs 5,132.55 on 28 September 2026, down 2.61% from the previous close, with the company valued at Rs 63,010.16 crore. The move places Alkem Laboratories in focus for investors tracking Alkem Laboratories Share Price Today, Alkem Laboratories Stock News and the broader Alkem Laboratories Share Price fall. The supplied data confirms the price event, but it does not establish a company-specific catalyst for the decline.
The stock opened at Rs 5,307.35, matched that as the day high, and later touched a low of Rs 5,118.45 before closing at Rs 5,132.55. Turnover stood at Rs 16.74 crore. In the context of Alkem Laboratories Share Price News, the day’s decline is meaningful because it comes after a relatively wide intraday range and against a large-cap market capitalisation base. Univest is tracking the move because the current quote, the day’s range and the valuation backdrop together help frame Alkem Laboratories Share Price today.
Alkem Laboratories (ALKEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,132.55 |
| Previous Close | Rs 5,269.95 |
| Today's Move | -Rs 137.40 (-2.61%) |
| Open | Rs 5,307.35 |
| High | Rs 5,307.35 |
| Low | Rs 5,118.45 |
| Turnover | Rs 16.74 crore |
| Market Capitalisation | Rs 63,010.16 crore |
| Market Cap Category | Large Cap |
Alkem Laboratories Share Price Today shows a clear one-day decline, with the stock closing at Rs 5,132.55 versus the previous close of Rs 5,269.95. The absolute fall was Rs 137.40 and the percentage change was -2.61%. The session began at Rs 5,307.35, stayed capped at that level as the day high, and later moved to Rs 5,118.45 as the day low. That places the close near the lower end of the day’s range.
The company’s market capitalisation of Rs 63,010.16 crore places it in the Large Cap category, which is useful context for Alkem Laboratories Share Price analysis. Turnover was Rs 16.74 crore, and that is the exact value visible in the data. For investors scanning Alkem Laboratories Stock Falling Today or Alkem Laboratories Share Price Fall, the key point is simple: the day’s price action confirms a notable decline, while the supplied information does not establish a company-specific trigger. The next layer of analysis therefore comes from fundamentals and sector comparison rather than a stated event driver.
Alkem Laboratories (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 63,010.16 crore |
| P/E Ratio | 29.21x |
| P/B Ratio | 4.4x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 1.01% |
Alkem Laboratories Share Price can be read alongside a set of fairly detailed fundamentals. The stock is trading at a P/E ratio of 29.21 and a P/B ratio of 4.4. Its ROE stands at 18.29% and ROCE at 21.28%, both of which are useful profitability and capital-efficiency measures when compared with sector benchmarks. EPS is Rs 180.45, book value is Rs 1,196.51 per share and dividend yield is 1.01%. These figures give Alkem Laboratories Share Price more context than price action alone.
On valuation, the P/E and P/B need to be viewed alongside the healthcare and pharmaceuticals universe rather than in isolation. The market cap of Rs 63,010.16 crore indicates company size, while the earnings and book-value metrics help explain why Alkem Laboratories Stock News often draws investor attention beyond one trading session. Univest uses these exact numbers to separate event-driven movement from the longer-term financial picture. For Alkem Laboratories Share News, the key takeaway is that the stock is not trading on price alone; the supplied financial ratios show a profitable business with a visible asset and earnings base.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.21x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 49.63x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 4.4x |
| Benchmark Median P/B | 2.85x |
| Benchmark Average P/B | 4.33x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.48% |
| Benchmark Average ROE | 10.04% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.82% |
| Company Market Capitalisation | Rs 63,010.16 crore |
| Benchmark Median Market Cap | Rs 732.57 crore |
| Benchmark Average Market Cap | Rs 14,043.26 crore |
Alkem Laboratories Share Price sits within the Healthcare sector and the Pharmaceuticals & Drugs industry, where the benchmark universe includes 204 companies. In that same industry set, the company’s P/E of 29.21 is below the benchmark median of 32.87 and far below the benchmark average of 49.63. Its P/B of 4.4 is above the benchmark median of 2.85 and close to the benchmark average of 4.33. ROE at 18.29% is above the benchmark median of 11.48%, while ROCE at 21.28% is above the benchmark median of 13.17%.
The sector data also shows a market-cap median of Rs 732.57 crore and an average of Rs 14,043.26 crore for the same-industry set, placing Alkem Laboratories Share Price within a much larger company profile than the median benchmark name. That context is important for Alkem Laboratories Fundamental Analysis because it frames the stock against peers in the healthcare and pharmaceuticals space rather than in the wider market. Univest highlights this comparison so readers can see whether the stock’s valuation and profitability sit above or below the benchmark range on exact numbers, not assumptions.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,44,716.74 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,55,115.31 | 87.22 | 14.44 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,613.38 | 86.94 | 21.13 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,899.96 | 26.57 | 4.45 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,875.68 | 33.49 | 3.21 | 11.83 | 16 |
Peer comparison helps position Alkem Laboratories Share Price against other listed pharmaceutical names. Compared with Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, Alkem’s P/E of 29.21 is below several higher-multiple peers such as Divi’s and Torrent, and slightly above Zydus. Its ROE of 18.29% is above Sun Pharma and Cipla, though below Torrent and Zydus.
ROCE at 21.28% is also competitive versus Sun Pharma, Divi’s, Torrent and Cipla, while the market capitalisation of Rs 63,010.16 crore is lower than each of the five listed peers in the supplied comparison set. For Alkem Laboratories Share Price Today, that means the stock is neither the largest nor the most expensive name in the sample, but it does show a solid return profile. Univest uses this peer frame to keep Alkem Laboratories Stock News tied to measurable valuation and profitability differences.
Why Investors Are Watching Alkem Laboratories
- Alkem Laboratories Share Price fell 2.61% today to Rs 5,132.55, versus the previous close of Rs 5,269.95.
- The day’s range ran from Rs 5,307.35 to Rs 5,118.45, showing a wider intraday move for Alkem Laboratories Share Price Today.
- Market capitalisation stands at Rs 63,010.16 crore, placing the company in the Large Cap category.
- The stock’s P/E is 29.21, P/B is 4.4, ROE is 18.29% and ROCE is 21.28%.
- In the same industry benchmark, Alkem Laboratories Share Price sits below the median P/E of 32.87 and above the median ROE of 11.48%.
About Alkem Laboratories
Alkem Laboratories operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied dataset confirms its market capitalisation, valuation ratios and profitability metrics, which are the core facts used in this Alkem Laboratories Share Price note. In Univest stock coverage, that combination of sector, industry and company-level metrics is the basis for understanding Alkem Laboratories Stock News and Alkem Laboratories Stock Analysis.
The current snapshot also includes EPS of Rs 180.45, book value of Rs 1,196.51 and dividend yield of 1.01%. These values help define the financial profile behind Alkem Laboratories Share Price Today. Readers using Univest for Alkem Laboratories Latest News can pair this company overview with benchmark data, peer comparison and the day’s market move.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories (ALKEM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Alkem Laboratories Share Price fall today?
Ans. The supplied data confirms that Alkem Laboratories Share Price fell 2.61% today, but it does not establish a company-specific catalyst. The stock closed at Rs 5,132.55 after opening at Rs 5,307.35.
What is Alkem Laboratories Share Price today?
Ans. Alkem Laboratories Share Price today is Rs 5,132.55. That is Rs 137.40 below the previous close of Rs 5,269.95 and reflects the day’s -2.61% move in the latest session. The previous close was Rs 5,269.95.
What is Alkem Laboratories market capitalisation?
Ans. Alkem Laboratories has a market capitalisation of Rs 63,010.16 crore. The supplied market-cap category is Large Cap, which provides company-size context for Alkem Laboratories Share Price and sector comparison. The company operates in the Healthcare sector.
How does Alkem Laboratories compare with healthcare peers?
Ans. Compared with the supplied peer set, Alkem Laboratories Share Price has a lower market cap than all five listed peers, a P/E below Divi’s and Torrent, and ROE above Sun Pharma and Cipla.
What do Alkem Laboratories valuation ratios show?
Ans. Alkem Laboratories reports a P/E of 29.21 and P/B of 4.4. Its ROE of 18.29% and ROCE of 21.28% add profitability context to Alkem Laboratories Share Price and fundamental analysis.
What are Alkem Laboratories EPS, book value and dividend yield?
Ans. EPS is Rs 180.45, book value is Rs 1,196.51 per share and dividend yield is 1.01%. These figures help explain the financial profile behind Alkem Laboratories Share Price and stock news.
